These Numbers Could Change Investor Views For Ginkgo Bioworks Holdings Inc (NYSE: DNA)
Currently, there are 1.53B common shares owned by the public and among those 1.39B shares have been available to trade. The company’s stock has a 5-day price change of -20.32% and -46.04% over the past three months. DNA shares are trading -54.98% year to date (YTD), with the 12-month market performance down to -43.64% lower. […]
Reviewing The Case For Ginkgo Bioworks Holdings Inc (DNA) Going Higher
Currently, there are 1.53B common shares owned by the public and among those 1.39B shares have been available to trade. The company’s stock has a 5-day price change of 11.03% and -24.80% over the past three months. DNA shares are trading -43.49% year to date (YTD), with the 12-month market performance down to -16.96% lower. […]
These Numbers Could Change Investor Views For Ginkgo Bioworks Holdings Inc (NYSE: DNA)
Currently, there are 1.53B common shares owned by the public and among those 1.35B shares have been available to trade. The company’s stock has a 5-day price change of -0.55% and -33.33% over the past three months. DNA shares are trading -49.11% year to date (YTD), with the 12-month market performance down to -27.72% lower. […]
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Loses -57.56% From High. Why That Could Change?
Currently, there are 1.53B common shares owned by the public and among those 1.34B shares have been available to trade. The company’s stock has a 5-day price change of -6.90% and -30.77% over the past three months. DNA shares are trading -36.09% year to date (YTD), with the 12-month market performance down to -13.60% lower. […]
Ginkgo Bioworks Holdings Inc (NYSE: DNA): Hunting Genuine Value In Market Debris
Currently, there are 1.53B common shares owned by the public and among those 1.34B shares have been available to trade. The company’s stock has a 5-day price change of 1.75% and -34.46% over the past three months. DNA shares are trading -31.36% year to date (YTD), with the 12-month market performance down to -3.33% lower. […]
Do Ginkgo Bioworks Holdings Inc (NYSE: DNA) Fit In A Value Investing Philosophy?
Currently, there are 1.53B common shares owned by the public and among those 1.34B shares have been available to trade. However, the script later moved the day high at 1.1100, up 1.89%. The company’s stock has a 5-day price change of -11.48% and -25.00% over the past three months. DNA shares are trading -36.09% year […]
Ginkgo Bioworks Holdings Inc (NYSE: DNA) – Suitable For Long Term Buy?
Currently, there are 1.53B common shares owned by the public and among those 1.34B shares have been available to trade. The company’s stock has a 5-day price change of -5.43% and -6.15% over the past three months. DNA shares are trading -27.81% year to date (YTD), with the 12-month market performance down to -7.58% lower. […]
Reviewing The Case For Ginkgo Bioworks Holdings Inc (DNA) Going Higher
Currently, there are 1.53B common shares owned by the public and among those 1.32B shares have been available to trade. Insiders at the company have transacted a total of 244 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 33 of these insider trades were purchases, […]
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Has Another Chance To Impress You
Currently, there are 1.34B common shares owned by the public and among those 1.32B shares have been available to trade. Insiders at the company have transacted a total of 250 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 36 of these insider trades were purchases, […]
Reassessing The Changing Outlook For Ginkgo Bioworks Holdings Inc (DNA)
Currently, there are 1.34B common shares owned by the public and among those 1.32B shares have been available to trade. Insiders at the company have transacted a total of 256 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 36 of these insider trades were purchases, […]
